🇺🇸 FDA
Patent

US 6977245

Oligodeoxynucleotide and its use to induce an immune response

expired A61KA61K2039/55561A61K31/7088

Quick answer

US patent 6977245 (Oligodeoxynucleotide and its use to induce an immune response) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55561, A61K31/7088, A61K39/008, A61K39/39